Monday, August 18, 2014

Top Managed Healthcare Companies To Own For 2014

Shares of Tesla (TSLA) have surged in after-hours trading after the upstart automaker announced better-than-forecast earnings.

Reuters Elon Musk, Chief Executive of Tesla Motors

Tesla said it earned 33 cents a share, above forecasts for 21 cents, on sales of $761 million, ahead of forecasts for $677.36 million. Tesla also said it would produce 7,400 cars during the first quarter, up from 6,587 during the fourth quarter. Even better, Tesla’s profit margins should increase to 28% by the end of 2014, the company said, up from 25.2% in the fourth quarter. The only bad news: Tesla predicted that its operating expenses would grow by 15% during the first quarter of 2014, while research & development costs would also rise.

Shares of Tesla have gained 14% to $220.92 in after-hours trading after dropping 4.9% during market hours.

Top 5 Low Price Companies To Watch In Right Now: Stillwater Mining Company(SWC)

Stillwater Mining Company engages in developing, extracting, processing, smelting, refining, and marketing palladium, platinum, and platinum group metals (PGMs). The company conducts its mining operations at the Stillwater mine, which is located near Nye, Montana; and at the East Boulder mine located near Big Timber, Montana. It is also involved in developing Marathon, a PGM/copper property, which is located in Ontario, Canada; and exploring Altar, a copper/gold property located in San Juan, Argentina. In addition, the company operates a smelter and base metal refinery located in Columbus, Montana. Further, it recycles spent catalyst material to recover palladium, platinum, and rhodium at its smelter and base metal refinery. As of December 31, 2011, the company had proven and probable ore reserves of approximately 42.5 million tons at its Montana operations; and approximately 91.4 million tones at the Marathon development project. Stillwater Mining Company was founded in 1 992 and is headquartered in Billings, Montana.

Advisors' Opinion:
  • [By Rich Duprey]

    Stillwater Mining (NYSE: SWC  ) says it disagrees with a shareholder advisory service's support of some of the board candidates put forth by a dissident shareholder. However, the company said in a press release today that it takes heart from some of the service's conclusions about shortcomings in the attempt by Clinton Group to force change at the company.

  • [By Mani]

    Outside of South Africa, only a few listed companies operate in this space, Stillwater Mining Company (NYSE:SWC) is one among them. Stillwater has steered clear of the flawed copper strategy and is now re-focused on making more of the PGM asset base.

Top Managed Healthcare Companies To Own For 2014: FirstService Corporation (FSRV)

FirstService Corporation provides real estate related services to commercial, institutional, and residential customers in North America and internationally. The company operates in three segments: Commercial Real Estate Services, Residential Property Management, and Property Services. The Commercial Real Estate Services segment offers brokerage, property management and maintenance, valuation, project management, and corporate advisory services primarily on office, industrial, retail, and multi-unit residential properties to owners, investors, tenants, corporations, financial institutions, governments, and individuals. The Residential Property Management segment manages private residential communities, including condominiums, cooperatives, homeowner associations, and various other residential developments governed by multi-unit residential community associations. This segment provides a range of property management services comprising facility maintenance, landscaping, swim ming pool management, home service contracts, energy usage benchmarking and retrofit consulting, real estate sales and leasing, heating, air conditioning, and concierge services. The Property Services segment offers various residential and commercial services through delivery channels, such as contractor network, franchise networks, and branchises. It provides property preservation, maintenance, repair, and inspection services to residential mortgage lenders and servicers for properties in the delinquency and foreclosure process; residential and commercial restoration services serving the insurance restoration industry; residential and commercial painting, and decorating services; installed closet and home storage systems; exterior residential painting and window cleaning services; home repair and remodeling service franchise; home inspection; and residential floor coverings design and installation services. FirstService Corporation was founded in 1972 and is headquartered i n Toronto, Canada.

Advisors' Opinion:
  • [By Seth Jayson]

    FirstService (Nasdaq: FSRV  ) reported earnings on April 26. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended March 31 (Q1), FirstService missed slightly on revenues and missed expectations on earnings per share.

Top Managed Healthcare Companies To Own For 2014: Telus Corporation(TU)

TELUS Corporation provides telecommunications products and services primarily in Canada. Its telecommunications products and services include wireless, data, Internet protocol (IP), voice, and television. The company operates through two segments, Wireless and Wireline. The Wireless segment provides digital personal communications, equipment sales, and wireless Internet services. The Wireline segment offers voice local and voice long distance services; data services, which include television, and managed and legacy data services, as well as Internet, enhanced data, and hosting services; and other telecommunications services. TELUS Corporation was founded in 1993 and is based in Burnaby, Canada.

Advisors' Opinion:
  • [By Rich Duprey]

    Continuing with its practice of raising its dividend payment every year, Canadian telecom�Telus� (NYSE: TU  ) �announced today�its second-quarter dividend of $0.34 Canadian per share. Last quarter�the payout was $0.32 Canadian per share. That's a 6.25% increase.

  • [By Tom Taulli]

    Big competitors for BCE include Rogers Communications (RCI) and Telus (TU), though it also faces niche players such as Public Mobile, Wind Mobile and Mobilicity. Until recently, there was buzz that Verizon (VZ) might enter the market by buying up the latter two, though VZ apparently scrapped plans for Canadian expansion until 2014.

Top Managed Healthcare Companies To Own For 2014: AEterna Zentaris Inc.(AEZS)

Aeterna Zentaris Inc. operates as a late-stage drug development company specialized in oncology and endocrine therapy. Its lead oncology compounds include perifosine, a PI3K/Akt pathway inhibitor that is in Phase 3 registration trial for refractory advanced colorectal cancer and multiple myeloma; and AEZS-108, a doxorubicin-targeted conjugate in Phase II for the treatment of ovarian, endometrial, castration refractory prostate, and refractory bladder cancer. The company?s lead endocrinology compound, AEZS-130, is an oral ghrelin antagonist in Phase III trial as a diagnostic test for adult growth hormone deficiency. Its pipeline also includes earlier-stage compounds, such as AEZS-112 that is in a Phase I trial in advanced solid tumors and lymphoma, as well as AEZS-120, an anti-cancer vaccine in pre-clinical development. The company was founded in 1991 and is headquartered in Quebec City, Canada.

Advisors' Opinion:
  • [By Sean Williams]

    What's coming down the pipeline
    As we saw with the current treatment options, the endometrial cancer pipeline isn't filled with a lot of choices, but they are at least more encouraging than the standard care treatments we've seen over the past three decades.

    Avastin: Surprise: It's Roche's (NASDAQOTH: RHHBY  ) wonder drug yet again! Roche's Avastin is in the process of being tested as a treatment for recurrent endometrial cancer and demonstrated promising results in a mid-stage trial according to the Journal of Clinical Oncology. Avastin, which is an angiogenesis inhibitor (a fancy way of saying it inhibits blood vessel growth), was tested on 52 evaluable patients and delivered a progression-free survival of at least six months for 21 of them. Overall median PFS was 4.2 months, and median overall survival came in at 10.5 months. Don't be surprised if Roche decides to pursue further studies of Avastin in recurrent endometrial cancer with these results.� AEZS-108: Currently in late-stage development by Aeterna Zentaris (NASDAQ: AEZS  ) , a holding in my own portfolio, AEZS-108 is an intravenous treatment composed of a synthetic peptide carrier and doxorubicin that targets Luteinizing Hormone Releasing Hormone-receptor expressing tumors. That series of scientific jargon simply means it targets cancer cells with minimal healthy cell death relative to the current standards of treatment. In mid-stage trials, AEZS-108 delivered an overall response rate of 30.8% and a clinical benefit rate of 74.4%. These figures were enough to get AEZS-108 a special protocol assessment (SPA), which should streamline its approval if these results stay consistent in late-stage studies.

    Your best investment
    With very few investable options to choose from, since many of these treatments are off patent as they're decades old, I'm going to split my decision this week between Roche and Aeterna Zentaris for obvious reasons.

  • [By Roberto Pedone]

    Aeterna Zentaris (AEZS), a specialty biopharmaceutical company, is focused on developing and commercializing novel treatments in oncology and endocrinology. This stock closed up 5% to $1.25 in Thursday's trading session.

    Thursday's Range: $1.19-$1.26
    52-Week Range: $0.99-$1.75
    Thursday's Volume: 1.32 million
    Three-Month Average Volume: 646,050

    From a technical perspective, AEZS ripped sharply higher here right above its 50-day moving average of $1.17 and back above its 200-day moving average of $1.22 with strong upside volume flows. This sharp spike higher on Thursday also pushed shares of AEZS into breakout territory, since the stock took out some more near-term overhead resistance at $1.23. This move is starting to push shares of AEZS within range of triggering another big breakout trade. That trade will hit if AEZS manages to take out some key overhead resistance levels at $1.28 to $1.35 with high volume.

    Traders should now look for long-biased trades in AEZS as long as it's trending above its 200-day at $1.22 or above Thursday's intraday low of $1.19 and then once it sustains a move or close above those breakout levels with volume that hits near or above 646,050 shares. If that breakout begins soon, then AEZS will set up to re-test or possibly take out its next major overhead resistance levels at $1.52 to $1.62.

No comments:

Post a Comment